Akari Therapeutics Analyst Ratings
HC Wainwright & Co. Initiates Coverage On Akari Therapeutics With Buy Rating, Announces Price Target of $1.5
Akari Therapeutics Analyst Ratings
Alliance Global Partners Initiates Coverage On Akari Therapeutics With Buy Rating, Announces Price Target of $4
No Data
No Data